March 18, 2020 / 9:12 PM / 22 days ago

BRIEF-Janssen Submits Ponesimod New Drug Application To The U.S. FDA For Treatment Of Adults With Relapsing Multiple Sclerosis

March 18 (Reuters) - Johnson & Johnson:

* JANSSEN SUBMITS PONESIMOD NEW DRUG APPLICATION TO THE U.S. FDA FOR TREATMENT OF ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

* JANSSEN - ANNOUNCED SUBMISSION OF A NDA TO U.S. FDA FOR PONESIMOD FOR TREATMENT OF ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below